![Isabelle de Baillenx](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Ms. Isabelle de Baillenx is Directrice Générale at FA Dièse-2 SAS in France.
Postes actifs de Isabelle de Baillenx
| Sociétés | Poste | Début |
|---|---|---|
FA Dièse SAS
 FA Dièse SAS Investment ManagersFinance The aim of FA Dièse is to enable entrepreneurs to mutually contribute their capital and know-how to business development projects with significant value-added potential. The firm accompanies and facilitates the development of their investee companies by leveraging their shareholders' networks. FA Dièse invests throughout France and across industries, with a preference for sectors such as biotechnology, environment, services, IT, Internet, specialized industrial machinery, electronics and advanced materials. They invest EUR 100 thousand to EUR 1 million per deal, typically in the second financing round, and may follow-up with subsequent investments. | Directeur Général | 23/07/2001 |
Flash Therapeutics SAS
 Flash Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Provides biotechnology products for medical research | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
10
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
FA Dièse SAS
FA Dièse SAS Investment ManagersFinance The aim of FA Dièse is to enable entrepreneurs to mutually contribute their capital and know-how to business development projects with significant value-added potential. The firm accompanies and facilitates the development of their investee companies by leveraging their shareholders' networks. FA Dièse invests throughout France and across industries, with a preference for sectors such as biotechnology, environment, services, IT, Internet, specialized industrial machinery, electronics and advanced materials. They invest EUR 100 thousand to EUR 1 million per deal, typically in the second financing round, and may follow-up with subsequent investments. | Finance |
Flash Therapeutics SAS
Flash Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Provides biotechnology products for medical research | Commercial Services |
Choisissez Zonebourse 
